Search Within

Gynecologic Medicine Service

Formats
  1. Journal Article (1104)
  2. Meeting Abstract (902)
  3. Review (55)
  4. Book Section (46)
  5. Editorial (36)
  6. Guidelines (22)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Solid Tumor Oncology Division (2180)
  2. Department of Medicine (2174)
  3. Gynecology Disease Management Team (1877)
  4. GDMT, Medicine (1859)
  5. Surgery (603)
  6. GDMT, Surgery (479)

More Groups

People
  1. Carol Aghajanian (615)
  2. Nadeem Abu-Rustum (292)
  3. Martee Hensley (290)
  4. Roisin O'Cearbhaill (273)
  5. Vicky Makker (269)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (75)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (458)
  2. Gynecologic Oncology (420)
  3. International Journal of Gynecological Cancer (161)
  4. Annals of Oncology (117)
  5. Clinical Cancer Research (71)
  6. Cancer Research (55)

More Publications

Publishers
  1. American Society of Clinical Oncology (498)
  2. Elsevier B.V. (446)
  3. Lippincott Williams & Wilkins (188)
  4. American Association for Cancer Research (173)
  5. Oxford University Press (144)
  6. Elsevier Inc. (128)

More Publishers

Results (2180)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized phase II trial of secondary cytoreductive surgery (SCS) plus /- carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with recurrent platinum-sensitive ovarian cancer (EOC)
    Meeting Abstract

    Zivanovic, O.; Chi, D.; Zhou, Q.; Iasonos, A.; Makker, V.; Grisham, R. N.; Konner, J. A.; Diaz, J. P.; Brown, A. K.; Langstraat, C. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase I/II study to evaluate systemic durvalumab plus intraperitoneal (IP) ONCOS-102 in patients with peritoneal disease who have epithelial ovarian (OC) or metastatic colorectal cancer (CRC): Interim phase I clinical and translational results
    Meeting Abstract

    Zamarin, D.; Odunsi, K.; Slomovitz, B. M.; Duska, L. R.; Nemunaitis, J. J.; Reilley, M.; Bykov, Y.; Holland, A.; Hubbard-Lucey, V. M.; Shohara, L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Characterization of patients (pts) with long-term responses to rucaparib in recurrent ovarian cancer (OC)
    Meeting Abstract

    Swisher, E. M.; Kristeleit, R. S.; Oza, A. M.; Tinker, A.; Ray-Coquard, I. L.; Oaknin, A.; Coleman, R. L.; Burris, H. A. 3rd; Aghajanian, C.; O'Malley, D. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Randomized phase II study of sapanisertib (SAP) plus paclitaxel (PAC) versus PAC alone in patients (pts) with advanced, recurrent, or persistent endometrial cancer
    Meeting Abstract

    Scambia, G.; Han, S. N.; Oza, A. M.; Colombo, N.; Oaknin, A.; Raspagliesi, F.; Wenham, R. M.; Braicu, E. I.; Jewell, A.; Makker, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Gastric-type adenocarcinoma of the cervix: Genomic drivers and clinical outcomes
    Meeting Abstract

    Sassine, D.; Straubhar, A. M.; Aghajanian, C.; Alektiar, K. M.; Broach, V.; Cadoo, K. A.; Jewell, E. L.; Kyi, C.; Leitao, M. M.; Mueller, J. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Clinical characteristics, genomic features, and recurrence risk of early-stage MET exon 14 mutant non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Recondo, G.; Guo, R.; Cravero, P.; Ricciuti, B.; Falcon, C.; Vokes, N.; Kris, M. G.; Leonardi, G. C.; Lamberti, G.; Nguyen, T.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A randomized multicenter phase II trial to evaluate the safety and efficacy of vaccination with folate receptor alpha (FRa) peptides admixed with GM-CSF as an adjuvant versus GM-CSF alone in patients with platinum-sensitive ovarian cancer (EOC)
    Meeting Abstract

    O'Cearbhaill, R. E.; Konner, J. A.; Block, M. S.; Potts, J.; Garrett, G.; Kenney, R.; Wenham, R. M.; TPIV200 Ovarian Cancer Study Group
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Lenvatinib (LEN) plus pembrolizumab (PEMBRO) for early-line treatment of advanced/recurrent endometrial cancer (EC)
    Meeting Abstract

    Makker, V.; Taylor, M. H.; Aghajanian, C.; Oaknin, A.; Mier, J.; Cohn, A. L.; Romeo, M.; Bratos, R.; Brose, M. S.; DiSimone, C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer
    Meeting Abstract

    Liu, J. F.; Brady, M. F.; Matulonis, U. A.; Miller, A.; Kohn, E. C.; Swisher, E. M.; Tew, W. P.; Cloven, N. G.; Muller, C.; Bender, D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prevalence and clinical characterization of MMR-D/MSI extra-colonic cancers among germline PMS2 mutation carriers
    Meeting Abstract

    Latham, A.; Salo-Mullen, E. E.; Catchings, A.; Ranganathan, M.; Fiala, E.; Kemel, Y.; Konner, J. A.; Soslow, R. A.; Momeni-Boroujeni, A.; Shia, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save